Free Trial

Lipella Pharmaceuticals (LIPO) SEC Filings & 10K Form

Lipella Pharmaceuticals logo
$0.71 +0.01 (+1.28%)
As of 08/1/2025 02:53 PM Eastern

Recent Lipella Pharmaceuticals SEC Filings

DateFilerForm TypeView
06/25/2025
2:14 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2025
3:25 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2025
4:05 PM
Lipella Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/01/2025
8:19 PM
Huang Leaf (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
04/14/2025
5:08 AM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2025
7:39 PM
Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
04/09/2025
7:43 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
04/09/2025
4:06 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/07/2025
6:16 PM
Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2025
6:20 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
04/07/2025
5:05 AM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2025
4:14 PM
Lipella Pharmaceuticals (Filer)
Form 424B5
04/03/2025
11:15 PM
Lipella Pharmaceuticals (Filer)
Form EFFECT
03/28/2025
5:21 AM
Lipella Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/27/2025
6:56 PM
Lipella Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/19/2025
5:23 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
03/18/2025
4:01 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/17/2025
7:18 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
03/17/2025
7:12 PM
Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:01 PM
Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:09 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
03/11/2025
4:26 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/24/2025
3:05 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2025
8:28 AM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2025
4:32 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
02/10/2025
4:35 PM
Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
01/30/2025
4:27 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
01/30/2025
4:28 PM
Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
01/23/2025
5:08 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
01/23/2025
5:11 PM
Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
01/17/2025
7:13 PM
Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
7:17 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
01/16/2025
5:51 AM
Lipella Pharmaceuticals (Filer)
Form 424B3
01/15/2025
11:15 PM
Lipella Pharmaceuticals (Filer)
Form EFFECT
01/13/2025
7:42 AM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
4:25 PM
Lipella Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/07/2025
4:28 PM
Lipella Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
01/06/2025
4:25 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2025
8:22 PM
Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
8:25 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
12/30/2024
3:11 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
One stock to replace Nvidia (Ad)

I'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce competitors, dethroning the AI Chip King. But there's a critical component that AI data centers need just as badly as chips. The demand is so massive that a single data center uses enough of it to stretch around the earth eight times. While the media hypes up AI chips, the smart money has found the next big thing. Discover Futurist Eric Fry's "Nvidia-killer" stock ideas.

Click here for complete analysis.
12/27/2024
8:28 PM
Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
8:31 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
12/27/2024
3:05 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2024
8:29 AM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
4:26 PM
Lipella Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
4:01 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2024
4:24 PM
Lipella Pharmaceuticals (Filer)
Form PRE 14A
11/01/2024
4:00 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2024
3:05 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
4:00 PM
Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
Form SC 13D/A
10/17/2024
4:00 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SC 13D/A
09/11/2024
4:10 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2024
3:05 PM
Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
Form SC 13D/A
08/13/2024
3:13 PM
Lipella Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2024
7:44 AM
Lipella Pharmaceuticals (Filer)
Form ARS
08/12/2024
7:25 AM
Lipella Pharmaceuticals (Filer)
Form DEF 14A
08/06/2024
3:50 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:LIPO) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners